Moscow, ID, United States of America

Valorie R Wiss

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Valorie R Wiss: Innovator in Tissue-Homing Peptide Conjugates

Introduction

Valorie R Wiss is a prominent inventor based in Moscow, ID (US). She has made significant contributions to the field of biotechnology, particularly in the development of tissue-homing peptide conjugates. With a total of 2 patents to her name, her work focuses on innovative methods for targeted delivery of pharmaceutical agents.

Latest Patents

Valorie's latest patents include groundbreaking research on tissue-homing peptide conjugates and methods of use thereof. These patents disclose peptides that can home, target, migrate to, and bind to specific tissues such as cartilage or kidneys in a subject. The pharmaceutical compositions developed from these peptides can be formulated for targeted delivery of active agents to designated regions, tissues, or cells. This innovative approach enhances the effectiveness of treatments by ensuring that therapeutic agents reach their intended targets.

Career Highlights

Valorie R Wiss is currently associated with Blaze Bioscience, Inc., where she continues to advance her research in peptide technology. Her work has garnered attention for its potential applications in medicine, particularly in improving drug delivery systems.

Collaborations

Some of her notable coworkers include Stacey J Hansen and Claudia Jochheim, who contribute to the collaborative efforts at Blaze Bioscience, Inc. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Valorie R Wiss stands out as a key figure in the field of biotechnology, with her innovative patents paving the way for advancements in targeted drug delivery. Her contributions are poised to make a significant impact on medical treatments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…